BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24299561)

  • 1. Integrated molecular portrait of non-small cell lung cancers.
    Lazar V; Suo C; Orear C; van den Oord J; Balogh Z; Guegan J; Job B; Meurice G; Ripoche H; Calza S; Hasmats J; Lundeberg J; Lacroix L; Vielh P; Dufour F; Lehtiö J; Napieralski R; Eggermont A; Schmitt M; Cadranel J; Besse B; Girard P; Blackhall F; Validire P; Soria JC; Dessen P; Hansson J; Pawitan Y
    BMC Med Genomics; 2013 Dec; 6():53. PubMed ID: 24299561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico comparative genomic analysis of two non-small cell lung cancer subtypes and their potentials for cancer classification.
    Li J; Li D; Wei X; Su Y
    Cancer Genomics Proteomics; 2014; 11(6):303-10. PubMed ID: 25422361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    BMC Cancer; 2009 Jul; 9():237. PubMed ID: 19607727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
    Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.
    Sriram KB; Larsen JE; Savarimuthu Francis SM; Wright CM; Clarke BE; Duhig EE; Brown KM; Hayward NK; Yang IA; Bowman RV; Fong KM
    PLoS One; 2012; 7(2):e30398. PubMed ID: 22363434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-dependent regulation of transcription in non-small cell lung cancer.
    Molina-Pinelo S; Gutiérrez G; Pastor MD; Hergueta M; Moreno-Bueno G; García-Carbonero R; Nogal A; Suárez R; Salinas A; Pozo-Rodríguez F; Lopez-Rios F; Agulló-Ortuño MT; Ferrer I; Perpiñá A; Palacios J; Carnero A; Paz-Ares L
    PLoS One; 2014; 9(3):e90524. PubMed ID: 24625834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
    Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
    Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
    Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
    Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
    Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
    Davidson MR; Larsen JE; Yang IA; Hayward NK; Clarke BE; Duhig EE; Passmore LH; Bowman RV; Fong KM
    PLoS One; 2010 Sep; 5(9):e12560. PubMed ID: 20838434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
    Liu M; Zhou K; Huang Y; Cao Y
    J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
    Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
    Pathol Res Pract; 2018 Mar; 214(3):368-373. PubMed ID: 29496309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.